April 11-12, 2022
Online Livestream
2nd Real World Evidenceand Market Access Symposium
Improve Health Care Decision Making, Patient Outcomes and Access
Days
Hours
Minutes
Seconds

Happy Holidays from DGE! Attend this conference with a colleague and BUY ONE, GET ONE FREE. Select the standard registration option and enter discount code HOLIDAYBOGO at checkout.

There is currently a tremendous opportunity to strengthen commercial and reimbursement strategies by improving scientific communication on how real world data and evidence support product effectiveness for patients, providers and payers. FDA published the guidance document on, “Real World Data: Assessing Electronic Health Records and Medical Claims Data to Support Regulatory Decision Making for Drug and Biological Products”, in September 2021. This shines the light even brighter on the importance of understanding how to leverage secondary data to complement and innovate clinical trials.
DGE invites you to join your colleagues at the 2nd Real World Evidence and Market Access Symposium to hear about the latest advances and best practices for harnessing the data insights that have the greatest impact on patient care. From identifying and accessing the right data to creating valuable insights that help pave the road to patient access, you will gain the critical approaches needed to focus your message on the patients who will benefit most from your therapy and work to further identify unmet patient needs.
Agenda at a Glance

Topics covered will include:

  • Build value maps for specific patient communities and improve scientific communication
  • Obtain methods for data collaboration including working with electronic health records, medical claims and patient registries
  • Gain knowledge into how RWE is being leveraged in oncology plus RWD and expanded access programs
  • Hear opinions on what to do and what not to do working with FDA
  • Use insight gained from RWD to make trials more inclusive and diverse
Attendee Profile
For professionals in pharmaceutical, biotech, and medical device companies responsible for:
  • Real World Evidence/Data/Analytics
  • Health Economics and Outcomes Research (HEOR)
  • Medical Affairs
  • Market Access
  • Marketing
  • Epidemiology
  • Drug/Patient Safety
  • Labeling
  • Data Analytics
  • Population Health
  • Observational Research/Studies
  • Post Approval
  • Clinical Operations/Development
  • Medical Scientific Affairs
  • Pricing/Reimbursement
  • Commercialization
  • Regulatory Affairs/Policy
Also relevant for solution providers focusing on:
  • Real world data and evidence platforms/solutions
  • Trial management software
  • Data management software
  • Digital platform technology
  • Data analytics
  • CROs
  • Artificial intelligence and machine learning
Top Reasons to Attend
  • Determine the most valuable data sources for payers – what do they want most?
  • Use real world data analytics to create successful market access inroads pre-launch, launch and post launch
  • Improve HEOR experience and applicability of artificial intelligence and machine learning in summarizing the value story
  • Communicate clinical, economic and quality of life endpoints of various treatments
  • Learn about using RWE to demonstrate value, support coverage decisions and pricing
Event Sponsors
Conference
New Topics
Event Pricing
Event Association Partners
Event Partners
15
Speakers
21
Days
251
Participants
125
Workshops
90
Venue
Share with Others

Help spread the word about this amazing event

Contact Us
Stay Connected Subscribe

Stay up to date on the latest announcements